These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 25517440)

  • 1. [New challenges and perspectives in nuclear medicine imaging].
    Borbély K
    Magy Onkol; 2014 Dec; 58(4):232-8. PubMed ID: 25517440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New trends and novel possibilities in the management of oncologic patients: clinical uses of PET/MRI].
    Borbély K
    Magy Onkol; 2015 Mar; 59(1):10-6. PubMed ID: 25763908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid SPECT/CT imaging in neurology.
    Ciarmiello A; Giovannini E; Meniconi M; Cuccurullo V; Gaeta MC
    Curr Radiopharm; 2014; 7(1):5-11. PubMed ID: 25143053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hybrid imaging: clinical evidence, opportunities].
    Trencsényi G; Barna SK; Garai I
    Orv Hetil; 2015 Dec; 156(52):2110-5. PubMed ID: 26686747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technological advances in hybrid imaging and impact on dose.
    Mattsson S; Andersson M; Söderberg M
    Radiat Prot Dosimetry; 2015 Jul; 165(1-4):410-5. PubMed ID: 25802466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Why is PET/CT essential in urooncology?].
    Borbély K; Géczi L; Kásler M
    Magy Onkol; 2013 Dec; 57(4):282-96. PubMed ID: 24353995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
    Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
    Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future Challenges of Multimodality Imaging.
    López-Mora DA; Lagos LA; Estorch M; Carrio I
    Recent Results Cancer Res; 2020; 216():905-918. PubMed ID: 32594412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation dose in nuclear medicine: the hybrid imaging.
    Salvatori M; Rizzo A; Rovera G; Indovina L; Schillaci O
    Radiol Med; 2019 Aug; 124(8):768-776. PubMed ID: 30771217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a role for PET-CT and SPECT-CT in pediatric oncology?
    Biermann M; Schwarzlmüller T; Fasmer KE; Reitan BC; Johnsen B; Rosendahl K
    Acta Radiol; 2013 Nov; 54(9):1037-45. PubMed ID: 23319723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
    Chavdarova LI; Tzonevska AD; Piperkova EN
    Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear medicine examinations of children in Russia.
    Zvonova I; Chipiga L; Balonov M; Ermolina E
    Radiat Prot Dosimetry; 2015 Jul; 165(1-4):216-9. PubMed ID: 25836687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pitfalls and Limitations of Radionuclide and Hybrid Imaging in Infection and Inflammation.
    Glaudemans AW; Israel O; Slart RH
    Semin Nucl Med; 2015 Nov; 45(6):500-12. PubMed ID: 26522392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybrid PET/MR imaging: physics and technical considerations.
    Shah SN; Huang SS
    Abdom Imaging; 2015 Aug; 40(6):1358-65. PubMed ID: 25985965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New trends and novel possibilities in the clinical use of SPECT/CT imaging].
    Zámbó K; Schmidt E; Szabó Z; Sarkadi M; Dérczy K; Szekeres S
    Magy Onkol; 2015 Mar; 59(1):17-24. PubMed ID: 25763909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability of target and normal structure delineation using multimodality imaging for radiation therapy of pancreatic cancer.
    Dalah E; Moraru I; Paulson E; Erickson B; Li XA
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):633-40. PubMed ID: 24755533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined imaging modalities: PET/CT and SPECT/CT.
    Maurer AH
    Health Phys; 2008 Nov; 95(5):571-6. PubMed ID: 18849691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of positron emission tomography, hybrid positron emission tomography instrumentation, and positron emission tomography quantification.
    Kwee TC; Torigian DA; Alavi A
    J Thorac Imaging; 2013 Jan; 28(1):4-10. PubMed ID: 23249967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.